With a portfolio spanning from prescription drugs and consumer healthcare products to dermo-cosmetics, Pierre Fabre is the second largest dermo-cosmetics laboratory in the world and the second largest private French pharmaceutical group.
Its portfolio includes several global brands and franchises, such as Pierre Fabre Dermatologie and Pierre Fabre Oncologie. Pierre Fabre is committed to delivering treatment options to patients with cancer and has been working with oncologists for 29 years to make a difference in their clinical practice.
Pierre Fabre is 86%-owned by the Pierre Fabre Foundation, a government-recognised public-interest foundation, and secondarily by its own employees.
1. Pierre Fabre. Activity and corporate social responsibility report 2016-17. Available at: http://radd.pierre-fabre.com/wp-content/uploads/2016/09/RADD-PF-2017_EN_IMA_BAT_WEB.pdf
. Accessed December 2018.